Antiangiogenic Therapy in Gastroesophageal Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2017.01.008
Abstract: Antiangiogenesis therapy is one of only 2 biologically targeted approaches shown to improve overall survival over standard of care in advanced adenocarcinoma of the stomach or gastroesophageal junction (GEJ). Therapeutic targeting of vascular endothelial growth… read more here.
Keywords: antiangiogenic therapy; therapy gastroesophageal; cancer; therapy ... See more keywords
Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment
Sign Up to like & getrecommendations! Published in 2017 at "Neuro-Oncology"
DOI: 10.1093/neuonc/now270
Abstract: Background In previous clinical trials, antiangiogenic therapies such as bevacizumab did not show efficacy in patients with newly diagnosed glioblastoma (GBM). This may be a result of the heterogeneity of GBM, which has a variety… read more here.
Keywords: antiangiogenic therapy; image; glioblastoma; perfusion ... See more keywords
[Antiangiogenic therapy in high-risk keratoplasty].
Sign Up to like & getrecommendations! Published in 2020 at "Vestnik oftalmologii"
DOI: 10.17116/oftalma202013604111
Abstract: PURPOSE To analyze the effectiveness and safety of VEGF inhibitor used to improve keratoconus transplant survival in patients with corneal neovascularization as stand-alone and in combination with laser coagulation of ingrowing vessels before keratoplasty. MATERIAL… read more here.
Keywords: risk keratoplasty; antiangiogenic therapy; high risk; group ... See more keywords
[Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration].
Sign Up to like & getrecommendations! Published in 2021 at "Vestnik oftalmologii"
DOI: 10.17116/oftalma20211370517
Abstract: The neovascular form of age-related macular degeneration (AMD) is characterized by growth of newly formed vessels, accumulation of fluid and, in most cases, presence of retinal pigment epithelium detachment. Depending on its localization in relation… read more here.
Keywords: antiangiogenic therapy; macular degeneration; age related; related macular ... See more keywords
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.873830
Abstract: Aim A programmed death 1 (PD-1) inhibitor coupled with radiotherapy and antiangiogenic therapy is a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC). We aimed to determine if circulating tumor cells (CTCs) positive for programmed… read more here.
Keywords: radiotherapy antiangiogenic; antiangiogenic therapy; therapy; predictive biomarker ... See more keywords
Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.992096
Abstract: Background and objective For patients with advanced colorectal liver metastases (CRLMs) receiving first-line anti-angiogenic therapy, an accurate, rapid and noninvasive indicator is urgently needed to predict its efficacy. In previous studies, dynamic radiomics predicted more… read more here.
Keywords: dynamic radiomics; efficacy; colorectal liver; antiangiogenic therapy ... See more keywords
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14041064
Abstract: Simple Summary In the latest WHO classification, solitary fibrous tumors (SFTs) are now subdivided into benign SFT (intermediate category (locally aggressive)), SFT NOS (intermediate category (rarely metastasizing)), and malignant SFT. Thanks to recent progress in… read more here.
Keywords: sft; treatment; antiangiogenic therapy; therapeutic options ... See more keywords
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14246245
Abstract: Simple Summary Resistance to antiangiogenic therapy represents a challenge in the therapeutic approach for hepatocellular carcinoma (HCC). The advent of immune checkpoint inhibitors (ICIs) seems to be a solution to this issue; however, other gaps… read more here.
Keywords: hepatocellular carcinoma; resistance antiangiogenic; molecular mechanisms; resistance ... See more keywords
Endothelial EphrinB2 Regulates Sunitinib Therapy Response in Murine Glioma
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12050691
Abstract: Vascular guidance is critical in developmental vasculogenesis and pathological angiogenesis. Brain tumors are strongly vascularized, and antiangiogenic therapy was anticipated to exhibit a strong anti-tumor effect in this tumor type. However, vascular endothelial growth factor… read more here.
Keywords: ephrinb2; endothelial ephrinb2; therapy; glioma ... See more keywords
Efficacy and safety of antiangiogenic therapy (bevacizumab or apatinib) plus chemotherapy in patients with platinum‑resistant recurrent ovarian cancer: A retrospective study
Sign Up to like & getrecommendations! Published in 2024 at "Oncology Letters"
DOI: 10.3892/ol.2024.14790
Abstract: The majority of patients with ovarian cancer will relapse and subsequently develop platinum-resistant recurrent ovarian cancer (PRROC). Antiangiogenic therapy plus chemotherapy may be a potential treatment option in patients with PRROC. However, further evidence is… read more here.
Keywords: treatment; ovarian cancer; antiangiogenic therapy; plus chemotherapy ... See more keywords